Sorry, haven't read the full thread but wanted to say this while it's clear in my mind.
As I understand it, the Tavistock has experimentally provided a drug to just-pre- and adolescent people.
This drug has been shown, by data which the Tavistock has collected, to reduce the bone-density of those who take it from the normal for that stage of development.
There is little doubt that reduced bone density in adolescence is directly related to such things as osteoporosis in later life.
Yet this is not a reason immediately to pause the experimental use of this drug in adolescents, as opposed to in the prematurely pubertal children for whom it was designed, until the matter has been fully investigated? Why the fuck not?
I cannot help remembering that recently, when a single individual out of a cohort of 30,000 being given an experimental vaccine suffered what might possibly have been an adverse reaction to that vaccine, that trial was immediately paused for full investigation in spite of the desperate need of millions of people for a working vaccine against SARS-CoV-2. Why the double standards?